Dr. Kaneko is a science advisor in the firm’s Business Law Department and a member of its Intellectual Property Group. She joined Goodwin in 2015.

Areas of Practice




Dr. Kaneko assists clients with prior art research, patent preparation, patent prosecution, and freedom to operate analyses. She has extensive experience in the fields of synthetic organic chemistry, pharmaceuticals, and biotechnology.

Professional Experience

Prior to joining Goodwin, Dr. Kaneko conducted doctoral research focused on the total synthesis of diazofluorene antitumor antibiotics and development of novel glycosylation methodology. Dr. Kaneko has presented her work at international conferences and authored scientific articles in peer-reviewed journals including Journal of American Chemical SocietyOrganic Letters, and Tetrahedron Letters. Dr. Kaneko also served as a technology commercialization intern at the Office of Cooperative Research at Yale University.





Ph.D., Organic Chemistry, 2015
Yale University
B.S., Chemistry, 2009
North Dakota State University
Get In Touch
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.


Search Other Lawyers